Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-viral gene therapy

F D Ledley1

  • 1Gene Medicine Inc, Houston.

Current Opinion in Biotechnology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Non-viral gene therapies use advanced drug-delivery methods to target genes for therapeutic expression. These methods show safety profiles comparable to conventional medicines, paving the way for treating common diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies.

Gene therapy·2013
Same author

Human gene marker/therapy clinical protocols.

Human gene therapy·2000
Same author

Human gene marker/therapy clinical protocols.

Human gene therapy·1999
Same author

Can pharmacogenomics make a difference in drug development?

Nature biotechnology·1999
Same author

Why pharmacogenomics? Why now?

Nature biotechnology·1998
Same author

Human gene marker/therapy clinical protocols.

Human gene therapy·1998
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Biotechnology
  • Molecular Medicine
  • Pharmacology

Background:

  • Non-viral gene therapy is emerging as a promising therapeutic strategy.
  • Current approaches involve various drug-delivery systems for gene targeting.

Purpose of the Study:

  • To review current non-viral gene therapy methods and their potential clinical applications.
  • To highlight the safety and efficacy profiles of these novel treatments.

Main Methods:

  • Review of existing literature on non-viral gene delivery techniques.
  • Analysis of preclinical and clinical study data for safety and efficacy.

Main Results:

  • Non-viral gene therapies utilize diverse formulations including DNA with lipids, proteins, peptides, or polymers.

Related Experiment Videos

  • Initial studies demonstrate safety profiles similar to conventional pharmaceuticals.
  • Clinical trials are underway for conditions like cystic fibrosis, cancer, and peripheral vascular disease.

    • Conclusions:

    • Non-viral gene therapy offers a viable alternative to traditional treatments.
    • These therapies are being developed for conventional administration and sustained therapeutic expression.
    • Non-viral gene therapy is poised for integration into clinical practice for common diseases.